Form 4 for ANIP ANI PHARMACEUTICALS INC
Accepted 2024-03-06 00:00:00 ET · period of report 2024-03-05 · accession 0001846487-24-000008 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-06 | 2024-03-05 | ANIP | Mutz Christopher | HEAD OF RARE DISEASE | S - Sale | $66.00 | -5,000 | 87.4K | -5% | -$330.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-05 | S | D | 5,000 | $66.00 | 87,387 | D | — | — | (F1) The shares were sold in multiple trades at prices ranging from $65.77 to $66.49. The price reported above reflects the weighted average sales price. |